Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.

Abrahão R, Ribeiro RC, Lichtensztajn DY, Rosenberg AS, Keegan THM.

Pediatr Blood Cancer. 2019 Apr;66(4):e27559. doi: 10.1002/pbc.27559. Epub 2018 Dec 4. Erratum in: Pediatr Blood Cancer. 2019 Jul;66(7):e27768.

PMID:
30511461
2.

A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.

Liu L, Moke DJ, Tsai KY, Hwang A, Freyer DR, Hamilton AS, Zhang J, Cockburn M, Deapen D.

J Natl Cancer Inst. 2019 May 1;111(5):509-518. doi: 10.1093/jnci/djy140.

PMID:
30321398
3.

Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.

Jaime-Pérez JC, Gamboa-Alonso CM, Vázquez-Mellado de Larracoechea A, Rodríguez-Martínez M, Gutiérrez-Aguirre CH, Marfil-Rivera LJ, Gómez-Almaguer D.

Arch Med Res. 2015 Aug;46(6):454-61. doi: 10.1016/j.arcmed.2015.07.004. Epub 2015 Jul 31.

PMID:
26235285
4.

Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab

Rasheed AA, Samad A, Raheem A, Hirani SI, Shabbir- Moosajee M.

Asian Pac J Cancer Prev. 2018 Feb 26;19(2):331-335.

5.

Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.

Haque W, Dabaja B, Tann A, Khan M, Szeja S, Butler EB, Teh BS.

Radiother Oncol. 2016 Jul;120(1):150-5. doi: 10.1016/j.radonc.2016.05.027. Epub 2016 Jun 30.

PMID:
27373911
6.

Insurance status is related to diffuse large B-cell lymphoma survival.

Han X, Jemal A, Flowers CR, Sineshaw H, Nastoupil LJ, Ward E.

Cancer. 2014 Apr 15;120(8):1220-7. doi: 10.1002/cncr.28549. Epub 2014 Jan 28.

7.

Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Hong JY, Ryu KJ, Park C, Hong M, Ko YH, Kim WS, Kim SJ.

Oncotarget. 2017 Feb 21;8(8):13782-13791. doi: 10.18632/oncotarget.14636.

8.

Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era.

Zaky AH, Bakry R, El-sayed MI, Elwanis MA, Nabih O.

Hematology. 2014 Oct;19(7):412-6. doi: 10.1179/1607845413Y.0000000147. Epub 2014 Jan 20.

PMID:
24620947
9.

[Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].

Fu ZY, Zhu J, Song YQ, Liu WP, Ji XQ, Zhan SY.

Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Jun 18;46(3):405-11. Chinese.

10.

Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.

Sato A, Nakamura N, Kojima M, Ohmachi K, Carreras J, Kikuti YY, Numata H, Ohgiya D, Tazume K, Amaki J, Moriuchi M, Miyamoto M, Aoyama Y, Kawai H, Ichiki A, Hara R, Kawada H, Ogawa Y, Ando K.

Cancer Sci. 2014 Sep;105(9):1170-5. doi: 10.1111/cas.12467. Epub 2014 Sep 8.

11.

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.

Cai QQ, Hu LY, Geng QR, Chen J, Lu ZH, Rao HL, Liu Q, Jiang WQ, Huang HQ, Lin TY, Xia ZJ.

Chin J Cancer. 2016 Sep 13;35(1):87. doi: 10.1186/s40880-016-0150-y.

12.

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.

Molina TJ, Canioni D, Copie-Bergman C, Recher C, Brière J, Haioun C, Berger F, Fermé C, Copin MC, Casasnovas O, Thieblemont C, Petrella T, Leroy K, Salles G, Fabiani B, Morschauser F, Mounier N, Coiffier B, Jardin F, Gaulard P, Jais JP, Tilly H.

J Clin Oncol. 2014 Dec 10;32(35):3996-4003. doi: 10.1200/JCO.2013.54.9493. Epub 2014 Nov 10.

PMID:
25385729
13.

[Analysis of survival and treatment outcome of young patients with high-risk diffuse large B cell lymphoma].

Yang P, Jing HM, Zhao W, Hu K, Dong F, Li QH, Wan W, Tian L, Wang JJ, Ke XY.

Zhonghua Yi Xue Za Zhi. 2017 Aug 22;97(32):2485-2490. doi: 10.3760/cma.j.issn.0376-2491.2017.32.003. Chinese.

PMID:
28835053
14.

Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.

Keegan TH, Grogan RH, Parsons HM, Tao L, White MG, Onel K, Horn-Ross PL.

Thyroid. 2015 Jun;25(6):635-48. doi: 10.1089/thy.2015.0021. Epub 2015 Apr 20.

15.

Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.

Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, Glaser SL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):264-73. doi: 10.1158/1055-9965.EPI-15-0756. Epub 2016 Jan 29.

16.

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.

Griffiths RI, Gleeson ML, Mikhael J, Dreyling MH, Danese MD.

Cancer. 2012 Dec 15;118(24):6079-88. doi: 10.1002/cncr.27638. Epub 2012 May 30.

17.

Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States.

Blum KA, Keller FG, Castellino S, Phan A, Flowers CR.

Br J Haematol. 2018 Nov;183(3):385-399. doi: 10.1111/bjh.15532. Epub 2018 Aug 10.

PMID:
30095154
18.

Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.

Williams JN, Rai A, Lipscomb J, Koff JL, Nastoupil LJ, Flowers CR.

Cancer. 2015 Jun 1;121(11):1800-8. doi: 10.1002/cncr.29290. Epub 2015 Feb 11.

19.

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.

Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, Hopfinger G, Greil R, Egle A.

Ann Oncol. 2014 Jan;25(1):171-6. doi: 10.1093/annonc/mdt481. Epub 2013 Dec 3.

PMID:
24299961

Supplemental Content

Support Center